AI Article Synopsis

  • SRSF1 is a protein that helps control how genes are spliced (cut and put together) and how proteins are made from those genes.
  • Researchers studied cells with a lot of SRSF1 and found around 1,500 different mRNAs (gene instructions) that SRSF1 helps to create proteins from, especially those important for cells dividing.
  • The study suggests that SRSF1 connects the processes of splicing and making proteins, which could be important for understanding cancer.

Article Abstract

The shuttling Serine/Arginine rich (SR) protein SRSF1 (previously known as SF2/ASF) is a splicing regulator that also activates translation in the cytoplasm. In order to dissect the gene network that is translationally regulated by SRSF1, we performed a high-throughput deep sequencing analysis of polysomal fractions in cells overexpressing SRSF1. We identified approximately 1,500 mRNAs that are translational targets of SRSF1. These include mRNAs encoding proteins involved in cell cycle regulation, such as spindle, kinetochore and M phase proteins, which are essential for accurate chromosome segregation. Indeed, we show that translational activity of SRSF1 is required for normal mitotic progression. Furthermore, we found that mRNAs that display alternative splicing changes upon SRSF1 overexpression are also its translational targets; strongly suggesting that SRSF1 couples pre-mRNA splicing and translation. These data provide insights on the complex role of SRSF1 in the control of gene expression at multiple levels and its implications in cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027812PMC
http://dx.doi.org/10.7554/eLife.02028DOI Listing

Publication Analysis

Top Keywords

srsf1
9
translational targets
8
translational
4
translational landscape
4
splicing
4
landscape splicing
4
splicing factor
4
factor srsf1
4
srsf1 role
4
role mitosis
4

Similar Publications

Esophageal squamous cell carcinoma (ESCC) is one of the main subtypes of esophageal carcinoma with high morbidity. This study aimed to explore the role of FKBP prolyl isomerase 11 (FKBP11) in ESCC and investigate the underlying mechanism. FKBP11 levels in ESCC tumor tissues and cell lines were measured.

View Article and Find Full Text PDF
Article Synopsis
  • Small extracellular vesicles (sEVs) in pancreatic ductal adenocarcinoma (PDAC) carry specific miRNAs that influence cancer progression, but the reasons for their selective enrichment are not fully understood.
  • The study focuses on Serine/Arginine-rich splicing factor 1 (SRSF1), an onco-protein overexpressed in PDAC, and how modifications like phosphorylation and arginine methylation affect sEV miRNA levels.
  • Treatment with arginine methyltransferase inhibitors increased levels of the specific miRNA miR-1246 in PDAC cells, suggesting that arginine methylation reduces SRSF1's ability to bind this miRNA and enrich it in sEVs,
View Article and Find Full Text PDF

Accumulating evidence has shown that long-term exposure to particulate matter with aerodynamic diameter of less than 2.5 μm (PM2.5) causes Th1/Th2 imbalance and increases the risk of allergic asthma (AA) in children.

View Article and Find Full Text PDF

Objective: To investigate the effect of different isoforms of on the proliferation of multiple myeloma (MM) cells after alternative splicing mediated by splicing factor .

Methods: RT-PCR was used to detect the expression levels of mRNA splicing isoforms regulated by . The GEO database was used to analyze the changes of isoform 1 in the progression of plasma cell disease, and survival analysis was used to evaluate the value of this gene in the prognosis of MM patients.

View Article and Find Full Text PDF

Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors.

J Nanobiotechnology

December 2024

Department of Urology, Guangzhou Women and Children's Medical Center, National Children's Medical Center for South Central Region, Guangzhou Medical University, Guangzhou, Guangdong, China.

Cancer cells acquire the ability to reprogram their phenotype in response to targeted therapies, yet the transition from dormancy to proliferation in drug-resistant cancers remains poorly understood. In prostate cancer, we utilized high-plasticity mouse models and enzalutamide-resistant (ENZ-R) cellular models to elucidate NR2F1 as a key factor in lineage transition and ENZ resistance. Depletion of NR2F1 drives ENZ-R cells into a relative dormancy state, characterized by reduced proliferation and heightened drug resistance, while NR2F1 overexpression yields contrasting outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!